An earlier study showed KRT80, RUNX, GATA6, SERPINB13, and SLC6a14 are important markers for prostate cancer progression (27), whereas we also identified KRT80, RUNX as well as GATA2, GATA2-AS1 in our study. This evidence concerns the gene GATA2 and prostate carcinoma.